Median treatment duration was 46.9 months (IQR 34.650.6), which is sufficient to evaluate the long-term outcome
Xu X, Sun Y, Cen X, Shan B, Zhao Q, Xie T, et al
Today, theyve become the cornerstone of modern diabetes treatment, and not just because they control glucose effectively
Your body needs to adapt to the glucagon receptor activation specifically, and no amount of GLP-1 tolerance from semaglutide or GLP-1/GIP tolerance from tirzepatide prepares you for that third receptor pathway
You should take one to two tablets daily, preferably after a meal or as directed by your healthcare provider